TABLE 3

11C-GR103545 Binding Parameters at Baseline and After Naloxone

RegionVT (mL/g)Baseline (n = 3) BP (mL/g)V3VT (mL/g)After naloxone (n = 3) BP (mL/g)V3
Cerebellum3.7 ± 1.63.4 ± 1.2
Brain stem5.1 ± 2.91.4 ± 1.30.3 ± 0.23.6 ± 1.80.3 ± 0.60.1 ± 0.2
Thalamus6.9 ± 3.63.2 ± 2.10.8 ± 0.34.1 ± 2.10.8 ± 0.90.2 ± 0.2
Striatum10.5 ± 5.96.8 ± 4.31.7 ± 0.54.7 ± 2.81.3 ± 1.50.3 ± 0.3
Medial temporal lobe7.0 ± 3.83.3 ± 2.10.8 ± 0.24.0 ± 1.80.6 ± 0.60.2 ± 0.1
Cingulate cortex10.9 ± 6.17.2 ± 4.51.9 ± 0.44.9 ± 2.31.6 ± 1.10.4 ± 0.1
Frontal cortex8.5 ± 3.74.8 ± 2.11.3 ± 0.24.3 ± 2.31.0 ± 1.10.2 ± 0.2
Temporal cortex8.1 ± 4.34.4 ± 2.71.1 ± 0.24.4 ± 2.11.0 ± 0.80.3 ± 0.1
Parietal cortex7.5 ± 3.83.7 ± 2.21.0 ± 0.24.1 ± 2.20.7 ± 1.00.2 ± 0.2
Occipital cortex4.9 ± 2.51.2 ± 0.90.3 ± 0.13.7 ± 1.70.3 ± 0.50.1 ± 0.1
  • Values are mean ± SD. Naloxone has no significant effect on VT in CER (P = 0.77; paired t test). Effect of naloxone on regional V3″ is highly significant (repeated-measures ANOVA, effect of condition, P ≤ 0.0001).